Esperion Therapeutics: 2Q Earnings Snapshot

August 2, 2018

ANN ARBOR, Mich. (AP) _ Esperion Therapeutics Inc. (ESPR) on Thursday reported a loss of $45.7 million in its second quarter.

The Ann Arbor, Michigan-based company said it had a loss of $1.71 per share.

The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.77 per share.

Esperion Therapeutics shares have decreased 32 percent since the beginning of the year. The stock has decreased slightly in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ESPR at https://www.zacks.com/ap/ESPR

Update hourly